Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Massive hyperoxaluria].

Frédéric Barbey1, François Cachat, Quan-Vinh Nguyen

  • 1Division de Néphrologie, CHUV, Lausanne. frederic.barbey@chuv.hospvd.ch

Revue Medicale De La Suisse Romande
|October 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive value of dipstick urinalysis for detecting pyelonephritis in children aged 0-12 months.

Frontiers in pediatrics·2026
Same author

Maternal exposure to high-fat diet induces long-term mitochondrial alterations in the offspring heart.

Nutrition (Burbank, Los Angeles County, Calif.)·2025
Same author

Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.

European heart journal·2025
Same author

Lysosphingolipid Quantitation in Plasma and Dried-Blood Spots Using Targeted High-Resolution Mass Spectrometry.

Journal of clinical laboratory analysis·2024
Same author

Myocardial fibrosis in the posterior myocardium in Fabry disease is associated with global rather than regional longitudinal strain reduction.

European heart journal. Cardiovascular Imaging·2024
Same author

Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy.

Heart (British Cardiac Society)·2024
Same journal

Accelerated sedimentation and hyperproteinemia.

Revue medicale de la Suisse romande·2010
Same journal

Treatment of a hydrothorax.

Revue medicale de la Suisse romande·2010
Same journal

Edema on pilgrim.

Revue medicale de la Suisse romande·2010
Same journal

Lymphosarcoma of the pancreatic compartment.

Revue medicale de la Suisse romande·2010
Same journal

Relief photography.

Revue medicale de la Suisse romande·2010
Same journal

Suture and nerve graft.

Revue medicale de la Suisse romande·2010
See all related articles

Primary hyperoxaluria, a metabolic disorder, causes severe kidney damage and premature death due to excessive oxalate. Early diagnosis and treatment are crucial for managing this rare condition.

Area of Science:

  • Metabolic disorders
  • Nephrology
  • Genetics

Background:

  • Primary hyperoxaluria (PH) encompasses genetic disorders of oxalate metabolism.
  • Type I PH results from a deficiency in a liver-specific enzyme, leading to overproduction of oxalate.

Observation:

  • Elevated oxalate levels cause kidney failure through urolithiasis and nephrocalcinosis.
  • Systemic oxalosis and a risk of premature death are consequences of untreated PH.
  • Enteric hyperoxaluria, linked to Crohn's disease or intestinal resection, is another significant cause of hyperoxaluria.

Findings:

  • PH types I and II, along with enteric hyperoxaluria, are primary drivers of massive hyperoxaluria.
  • These conditions, if not promptly identified and managed, can lead to rapid progression to end-stage renal disease.

Related Experiment Videos

Implications:

  • Urgent recognition and treatment of hyperoxaluria are vital to prevent irreversible kidney damage.
  • Understanding the distinct etiologies of hyperoxaluria is key for effective patient management and improved outcomes.